Investor Atlas

2080 Ventures · Investor research

35 Series D investors targeting Finland

Compare 35 Series D investors targeting Finland. Review the selection, investor types and reported focus with 2080 Ventures.

35matching investors
0individual investors
35organizations

What this selection covers

This guide contains 35 distinct directory identities matching target markets: Finland; funding stages & types: Series D. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting Finland” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Series D is a reported funding-stage or financing-type tag. Business milestones such as prototype or early revenue are kept separate.

Investor types represented: Venture Capital (33), Corporate Venture Capital (3), Private Equity (2), Angel Network (1).

Common reported sector tags: SaaS (26), Fintech (25), Healthcare (25), Enterprise (20). Investors can have multiple tags.

Prepare a focused approach

Start with the sector and business model you operate in, then narrow by funding round, target market and investor type.

Before pitching for Finland, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

For Series D, show the evidence already achieved, the next milestone and a budget connecting the raise to that milestone. Confirm expected round size and ownership.

  1. Check the current mandate and recent investments.
  2. Confirm check size, lead or follow preference, and company eligibility.
  3. Identify the relevant partner and published pitch route.
  4. Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 35 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

InvestorInvestor typeResearch
83North
Venture CapitalView profile ↗
Advent Life Sciences
Venture CapitalView profile ↗
Alven
Venture CapitalView profile ↗
Andreessen Horowitz
Venture CapitalView profile ↗
Atlantic Bridge
Venture CapitalView profile ↗
Atomico
Venture CapitalView profile ↗
Balderton Capital
Venture CapitalView profile ↗
Bosch Ventures
Venture Capital, Corporate Venture CapitalView profile ↗
Cipio Partners
Venture CapitalView profile ↗
Creandum
Venture CapitalView profile ↗
Dawn Capital
Venture CapitalView profile ↗
DN Capital
Venture CapitalView profile ↗
Eurazeo
Private EquityView profile ↗
Fuel Venture Capital
Venture CapitalView profile ↗
General Catalyst
Venture CapitalView profile ↗
Global Founders Capital
Venture Capital, Family OfficeView profile ↗
HealthCap
Venture CapitalView profile ↗
Highland Europe
Venture CapitalView profile ↗
IDInvest Partners
Private EquityView profile ↗
Index Ventures
Venture CapitalView profile ↗
Industrifonden
Venture CapitalView profile ↗
Inveready
Venture CapitalView profile ↗
Keiretsu Forum
Venture Capital, Angel NetworkView profile ↗
Kleiner Perkins
Venture CapitalView profile ↗
MVM Life Science Partners
Venture CapitalView profile ↗
Nauta Capital
Venture CapitalView profile ↗
Northzone
Venture CapitalView profile ↗
Novartis Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
Novo Holdings
Venture Capital, Corporate Venture CapitalView profile ↗
Prime Ventures
Venture CapitalView profile ↗
Runa Capital
Venture CapitalView profile ↗
Summit Partners
Venture CapitalView profile ↗
The Westly Group
Venture CapitalView profile ↗
Ventech
Venture CapitalView profile ↗
Wellington Partners
Venture CapitalView profile ↗

How these guides are compiled. Source-reported criteria may change. A listing does not confirm current investment activity.